Language Matters: Exploring the Impact of Language Concordance on Fertility Treatment Progression

Part of paid clinical trials in St Louis, Missouri.

Sponsor
Washington University School of Medicine
Study ID
NCT06636838
Status
Recruiting
Apply to this trial

Conditions

  • Infertility
  • Infertility (IVF Patients)
  • Infertility Assisted Reproductive Technology
  • Ovulation Ind

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Spanish-Speaking Provider — BEHAVIORAL
    Spanish speaking patients will be seen by our Spanish-speaking provider

Study Details

Currently, patients presenting to the Fertility and Reproductive Medicine Center meet with an English-speaking provider and communicate through an interpreter, as none of the physicians speak Spanish. However, this study PI is a native Spanish speaker and certified bilingual clinician. Thus, this study is looking to evaluate whether or not the use of an interpreter delays completion of testing and initiation of fertility treatment. The medically indicated testing, procedures, and course of treatment will not be altered as a result of participation in the study. Participants will be asked to complete a survey in their preferred language to gauge satisfaction and communication efficacy. This proposed study is significant as it seeks to address a critical gap in the understanding of how language concordance between healthcare providers and patients influences treatment outcomes in fertility care. With Spanish being the most commonly spoken non-English language in the U.S., evaluating the impact of Spanish language skills in medical care is both timely and essential. This research will shed light on whether Spanish-speaking patients experience better treatment progression and outcomes when cared for by language-concordant providers versus when interpreters are used in fertility care. This prospective study will be conducted at Washington University's Fertility and Reproductive Medicine Center over a 12-month period. The investigators aim to enroll a total of 70 Spanish-speaking patients, based on previous patient trends at the Center 35 will be randomized to the intervention group (being evaluated and treated by a Spanish-speaking provider), and 35 will be randomized to standard of care (communicating with an English-speaking provider through an interpreter).

Key Dates

Start date
Oct 15, 2024
Status verified
Mar 2025
Primary completion
Sep 30, 2025
Completion
Dec 30, 2025

Study Design

Enrollment
70 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • No Intervention: Spanish speaking patients seen by English-Speaking Provider
    Spanish speaking patients will be seen by our English-speaking providers using a qualified interpreter.
  • Experimental: Spanish-Speaking patients seen by a Spanish-speaking provider
    Spanish speaking patients will be seen by our Spanish-speaking provider

Primary Outcome Measure

Completion of diagnostic tests [ Time Frame: 90 days from initial consultation. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Washington University in St LouisSt LouisMissouri63108
Aileen Portugal, MD
[email protected]
619-993-4298
Aileen Portugal, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in St Louis, MO

By research site
Washington University in St Louis· St Louis, MO

Related Studies